Fatigue in Saudi Patients with Primary Sjögren’s Syndrome and Its Correlation with Disease Characteristics and Outcome Measures: A Cross-Sectional Study

References

• Retamozo S, Acar-Denizli N, Rasmussen A, et al. Systemic manifestations of primary Sjögren’s syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. Clin Exp Rheumatol. 2019.
   Web of Science ®Google Scholar
• Sandhya P, Kurien B, Danda D, Scofield R. Update on pathogenesis of Sjogren’s syndrome. Curr Rheumatol Rev. 2016. doi:10.2174/1573397112666160714164149
   Web of Science ®Google Scholar
• Bayetto K, Logan RM. Sjögren’s syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J. 2010;55:39–47. doi:10.1111/j.1834-7819.2010.01197.x20553243
   PubMed Web of Science ®Google Scholar
• Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983–1989. doi:10.1136/annrheumdis-2014-20537524938285
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Acar-Denizli N, Ng WF, et al. How immunological profile drives clinical phenotype of primary Sjögren’s syndrome at diagnosis: analysis of 10,500 patients (Sjögren big data project). Clin Exp Rheumatol. 2018.
   Web of Science ®Google Scholar
• Brito-Zerón P, Acar-Denizli N, Ng WF, et al. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren’s syndrome. Rheumatology (Oxford). 2020;59(9):2350–2359. doi:10.1093/rheumatology/kez57831873754
   PubMed Web of Science ®Google Scholar
• Barendregt PJ, Visser MRM, Smets EMA, et al. Fatigue in primary Sjogren’s syndrome. Ann Rheum Dis. 1998;57(5):291–295. doi:10.1136/ard.57.5.2919741313
   PubMed Web of Science ®Google Scholar
• Westhoff G, Dörner T, Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjögren’s syndrome: results from a cohort study. Rheumatology. 2012;51(2):262–269. doi:10.1093/rheumatology/ker20821705778
   PubMed Web of Science ®Google Scholar
• Lackner A, Ficjan A, Stradner MH, et al. It’s more than dryness and fatigue: the patient perspective on health-related quality of life in primary SjoÈgren’s syndrome - a qualitative study. PLoS One. 2017;12(2):e0172056. doi:10.1371/journal.pone.017205628182787
   PubMed Web of Science ®Google Scholar
• Jousse-Joulin S, Morvan J, Devauchelle-Pensec V, Saraux A. Ultrasound assessment of the entheses in primary Sjögren syndrome. Ultrasound Med Biol. 2013;39(12):2485–2487. doi:10.1016/j.ultrasmedbio.2013.05.01324035411
   PubMed Web of Science ®Google Scholar
• Singh AG, Singh S, Matteson EL. Rate, risk factors and causes of mortality in patients with Sjögren’s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatol. 2016. doi:10.1093/rheumatology/kev354
   Web of Science ®Google Scholar
• Miyamoto ST, Lendrem DW, Ng WF, Hackett KL, Valim V. Managing fatigue in patients with primary Sjögren’s syndrome: challenges and solutions. Open Access Rheumatol. 2019. doi:10.2147/OARRR.S167990
   Google Scholar
• Shiboski CH, Shiboski SC, Seror R, et al. 2016 American college of rheumatology/European league against rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheum. 2017;69(1):35–45. doi:10.1002/art.39859
   PubMed Web of Science ®Google Scholar
• Segal B, Thomas W, Rogers T, et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren’s syndrome. Arthritis Care Res. 2008;59(12):1780–1787. doi:10.1002/art.24311
   Web of Science ®Google Scholar
• Krupp LB. The fatigue severity scale. Arch Neurol. 1989;46(10):1121. doi:10.1001/archneur.1989.005204601150222803071
   PubMed Web of Science ®Google Scholar
• Al-Sobayel HI, Al-Hugail HA, Alsaif RM, et al. Validation of an Arabic version of fatigue severity scale. Saudi Med J. 2016;37(1):73–78. doi:10.15537/smj.2016.1.1305526739978
   PubMed Web of Science ®Google Scholar
• Seror R, Bootsma H, Saraux A, et al. Defining disease activity states and clinically meaningful improvement in primary Sjögren’s syndrome with EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis. 2016;75(2):382–389. doi:10.1136/annrheumdis-2014-20600825480887
   PubMed Web of Science ®Google Scholar
• Brito-Zerón P, Theander E, Baldini C, et al. Early diagnosis of primary Sjögrens syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol. 2016;12(2):137–156. doi:10.1586/1744666X.2016.110944926691952
   PubMed Web of Science ®Google Scholar
• Seror R, Theander E, Brun JG, et al. Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis. 2015;74(5):859–866. doi:10.1136/annrheumdis-2013-20461524442883
   PubMed Web of Science ®Google Scholar
• Meijer JM, Meiners PM, Slater JJRH, et al. Health-related quality of life, employment and disability in patients with Sjögren’s syndrome. Rheumatology. 2009;48(9):1077–1082. doi:10.1093/rheumatology/kep14119553376
   PubMed Web of Science ®Google Scholar
• Cornec D, Devauchelle-Pensec V, Mariette X, et al. Severe health-related quality of life impairment in active primary Sjögren’s syndrome and patient-reported outcomes: data from a large therapeutic trial. Arthritis Care Res. 2017;69(4):528–535. doi:10.1002/acr.22974
   Web of Science ®Google Scholar
• Haldorsen K, Bjelland I, Bolstad AI, Jonsson R, Brun JG. A five-year prospective study of fatigue in primary Sjögren’s syndrome. Arthritis Res Ther. 2011;13(5):R167. doi:10.1186/ar348721996338
   PubMed Web of Science ®Google Scholar
• Norheim KB, Harboe E, Gøransson LG, Omdal R. Interleukin-1 inhibition and fatigue in primary Sjögren’s syndrome - a double blind, randomised clinical trial. PLoS One. 2012;7(1):e30123. doi:10.1371/journal.pone.003012322253903
   PubMed Web of Science ®Google Scholar
• Yacoub YI, Rostom S, Laatiris A, Hajjaj-Hassouni N. Primary Sjögren’s syndrome in Moroccan patients: characteristics, fatigue and quality of life. Rheumatol Int. 2012. doi:10.1007/s00296-011-2009-5
   Web of Science ®Google Scholar
• Milin M, Cornec D, Chastaing M, et al. Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sjögren’s syndrome. Joint Bone Spine. 2016;83(6):681–685. doi:10.1016/j.jbspin.2015.10.00526774177
   PubMed Web of Science ®Google Scholar